This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Pirfenidone — Description, Dosage, Side Effects | PillsCard
OTC
Pirfenidone
INN: pirfenidone
Data updated: 2026-05-12
Available in:
🇨🇿🇩🇪🇬🇧🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
H.A.C. Pharma
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
ATC Code
L04AX05
Source
EMA · EMEA/H/C/002154
EUEMA:by INNUSDailyMed:Pirfenidone
AU:B3
L04AX05(WHO)
AU:S4(Prescription only)CA:℞-onlyUK:POM(Prescription only)US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only)
5-Methyl-1-phenylpyridin-2-one
53179-13-8
40632
DB04951
37115
D7NLD2JX7U
D01583Y
CHEBI:32016Y
ChEMBL1256391N
DTXSID4045183
Interactive image
CC1=CN(C(=O)C=C1)C2=CC=CC=C2
InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3Key:ISWRGOKTTBVCFA-UHFFFAOYSA-N
Pirfenidone, sold under the brand nameEsbrietamong others, is amedicationused for the treatment ofidiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production ofgrowth factorsandprocollagensI and II.
It was first approved in Japan for the treatment of people with idiopathic pulmonary fibrosis after clinical trials in 2008. It was approved for use in the European Union in 2011,in Canada in 2012,and in the United States in October 2014.
It is available as ageneric medication.
⚠️ Warnings
• Liver enzymes could increase during pirfenidone therapy. The levels to be monitored for either temporary dosage adjustment or discontinuation of the therapy.
• Rashes and sensitivity to sunlight, tanning beds and other fluorescent lamps can occur. Avoid direct sun exposure by using sunscreen (SPF- sun protection factor- 50 or even higher), protective clothing and sun glasses.
• The safety of pirfenidone in children is not known.